Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
03/2012
03/27/2012US8143303 Carbazole derivatives as functional 5-HT6 ligands
03/27/2012US8143291 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
03/27/2012US8143283 Methods for treating blood-born tumors with thalidomide
03/27/2012US8143259 Cold menthol receptor antagonists
03/27/2012CA2554642C Bicyclic carbonyl amino derivatives as chemokine receptor antagonists
03/27/2012CA2527141C Polyhydroxy phenols and their use in binding p-selectin
03/27/2012CA2496203C Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
03/22/2012WO2012035666A1 Acrylic ester derivative, alcohol derivative, and method for producing same
03/22/2012WO2012035406A1 Tryptamine derivatives, their preparation and their use in gastropathy
03/22/2012WO2012035123A1 Arylosulfonamides for the treatment of cns diseases
03/22/2012WO2012035061A1 Process for the preparation of 1,2-diamines by intermolecular transfer of two nitrogen groups onto alkenes and intermediates thereof
03/22/2012WO2012015274A3 Organic electroluminescent device employing organic light emitting compound as light emitting material
03/22/2012WO2012015269A9 Phosphaphenanthrene-carbazole-based organic light-emitting compound, and organic light-emitting device comprising same
03/22/2012WO2012001308A9 Method for synthesizing ergoline alkaloids from indolic bicyclic compounds by double cyclization, resulting materials, and intermediate materials
03/22/2012US20120071667 Acrylate derivatives, alcohol derivatives, and method for producing them
03/22/2012US20120071537 New Oral Formulation
03/22/2012US20120071536 N-[(2-azabicyclo[2.1.1]hex-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
03/22/2012US20120071503 Positive allosteric modulators of group ii mglurs
03/22/2012US20120070395 Novel amide derivative and whitening agent
03/22/2012US20120070385 Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
03/22/2012US20120068170 Materials for organic electroluminescent devices
03/22/2012US20120068164 Material for organic electroluminescent element and organic electroluminescent element employing the same
03/22/2012CA2808246A1 Arylosulfonamides for the treatment of cns diseases
03/21/2012EP2431370A1 Monoacylated 1,2-diaminocycloalkanes
03/21/2012EP2430678A1 Organic semiconductor material, organic semiconductor thin film, and organic thin-film transistor
03/21/2012EP2429991A1 Redox drug derivatives
03/21/2012EP2429987A2 Amide compound, preparation method thereof and pharmaceutical composition comprising same
03/21/2012EP2325169A9 Lisofylline analogues and their pharmeacuetical uses
03/21/2012EP2188254B1 Novel bradykinin b1-antagonists
03/21/2012EP2061318B1 Process for the synthesis of (+) and (-) -1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane
03/21/2012EP1320540B9 Peptidomimetic protease inhibitors
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
03/21/2012CN102388023A Organic compounds and their uses
03/21/2012CN102382058A Preparation method of N-aryl-heterocyclic nitrogen compound
03/21/2012CN102382038A Preparation method for synthesizing carbazoles alkaloid Siamenol
03/21/2012CN102382037A Benzene propanoic acid compound and preparation method and medicine use thereof
03/21/2012CN102382036A Phenoxyacetic acid compound, preparation method thereof and drug application
03/21/2012CN102382035A Method for preparing cis-exo-bicyclo [2.2.1] heptane-2, 3-dicarboximide
03/21/2012CN102382034A Synthetic method of N-amino-3-azabicyclo[3,3,0]octane hydrochloride
03/21/2012CN102382033A Preparation methods for optical activity mitiglinide ester and mitiglinide salt
03/21/2012CN102382032A 1-(phenyl)-4-[3-(4-indoxyl)-2-hydroxypropyl]piperazine derivative and salts thereof as well as preparation method and application thereof
03/21/2012CN102382031A 3 - substituted allylic ester oxindole and preparation method thereof
03/21/2012CN102382030A Separation and purification process for L-tryptophane
03/21/2012CN102382029A Preparation method of salt formation of silodosin intermediate
03/21/2012CN101845012B Method for synthesizing N-hydroxy phthalimide with solid-phase process
03/20/2012US8138352 Method for producing asymmetric tetrasubstituted carbon atom-containing compound
03/20/2012US8138221 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
03/20/2012US8138219 Tryptamine sulfonamides as 5-HT6 antagonists
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012US8138119 Alkoxyalkyl spirocyclic tetramic acids and tetronic acids
03/20/2012CA2579840C Carboxamide spirolactam cgrp receptor antagonists
03/20/2012CA2507765C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
03/20/2012CA2505029C Isoindoline derivatives
03/20/2012CA2396277C Condensed azepines as vasopressin agonists
03/15/2012WO2012034116A2 Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
03/15/2012WO2012033601A1 Thiosemicarbazones with mdr1 - inverse activity
03/15/2012WO2012033525A2 P53-mdm2 antagonists
03/15/2012WO2012033019A1 Acrylic ester derivative, high-molecular compound and photoresist composition
03/15/2012WO2011161255A3 Processes for the resolution of nitrogen substituted (s) - 5 -alkoxy- 2 -aminotetralin derivatives
03/15/2012WO2011131748A3 Benzimidazole derivatives as inhibitors of glutaminyl cyclase
03/15/2012US20120065396 Isoindolinone derivatives, preparation method thereof and a pharmaceutical composition comprising same
03/15/2012US20120065203 Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids
03/15/2012US20120064034 Peptidomimetic protease inhibitors
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012US20120060926 Polymerizable fullerene derivative and their use in organic photovoltaic cells
03/15/2012CA2810499A1 P53-mdm2 antagonists
03/14/2012EP2428586A1 Dimeric and trimeric nucleic acid dyes, and associated systems and methods
03/14/2012EP2427431A1 Novel indicator platform
03/14/2012EP2427430A1 5-oxo-ete receptor antagonist compounds
03/14/2012EP2427425A2 Tetracycline compounds
03/14/2012EP2024310B1 Materials for organic electroluminescent devices
03/14/2012EP1928828B1 Anthracene derivative
03/14/2012EP1910287B1 Process for the preparation of crystalline perindopril
03/14/2012CN102376899A Light emitting device and display unit
03/14/2012CN102372713A Dual alanyl-aminopeptidase and dipeptidyl-peptidase iv inhibitors
03/14/2012CN102372696A Phenylcarbazole compounds and application thereof
03/14/2012CN102372662A Dendrimer and organic light-emitting device using the same
03/14/2012CN102372661A Compound for organic optoelectronic device, organic light emmiting diode including the same and display including the light emmiting diode
03/14/2012CN102372660A N-phenylisatin and preparation method thereof
03/14/2012CN102372659A Indolebenzamide derivatives and medicinal applications thereof
03/13/2012US8134146 Heterocyclic radical or diradical, the dimers, oligomers, polymers, dispiro compounds and polycycles thereof, the use thereof, organic semiconductive material and electronic or optoelectronic component
03/13/2012US8134015 Compound inhibiting in vivo phosphorous transport and medicine containing the same
03/13/2012US8133914 Compounds and compositions thereof
03/13/2012US8133913 Substituted indeno [1,2-b]indole derivatives as novel inhibitors of protein kinase CK2 and their use as tumor therapeutic agents, cytostatics and diagnostic aids
03/13/2012US8133656 Oxime ester compound and photopolymerization initiator containing the same
03/13/2012CA2528174C Process for the preparation of cpla2 inhibitors
03/13/2012CA2419607C Peptidomimetic protease inhibitors
03/13/2012CA2361806C Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
03/08/2012WO2012029763A1 Diamine, polyimide precursor, polyimide, liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element
03/08/2012WO2012029253A1 Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using same
03/08/2012WO2012028676A1 New compounds, pharmaceutical compositions and uses thereof
03/08/2012WO2012028162A1 Process for preparing oxindoles and ortho-substituted anilines and the use thereof as intermediates for syntheses
03/08/2012US20120058996 Carbazole carboxamide compounds useful as kinase inhibitors
03/07/2012EP2426106A1 Piperidine and Piperazine derivatives for the treatment of tumours
03/07/2012EP2426105A1 Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1h-indole
03/07/2012EP2424918A2 Cure accelerators for anaerobic curable compositions
03/07/2012EP2424835A1 Method for producing oxindoles and ortho-substituted anilines and the use thereof as intermediate products for syntheses
03/07/2012EP2188253B1 Indol-2-one derivatives disubstituted in 3-position, preparation thereof and therapeutic use thereof
03/07/2012EP1352650B1 Inhibitors against the production and release of inflammatory cytokines
03/07/2012CN102369185A Indole derivatives for treating neurodegenerative diseases
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 458